跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Paclitero
Approved
STANDARD
Paclitero
Hetero Labs Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5066df1704766510
Company
Hetero Labs Limited
Type
Standard
Approval Details
Approval Id
5066df1704766510
Drug Approval Philippines Name
Paclitero
Product Name
Paclitero
Registration Number
DR-XY46101
Brand Name
Paclitero
Generic Name
Paclitaxel
Dosage Form
Solution for I.V. Infusion
Dosage Strength
6mg/mL
Manufacturer
Hetero Labs Limited
Importer
Camber Pharmaceuticlas, Inc.
Distributor
Camber Pharmaceuticlas, Inc.
Company Detail Path
/organization/hetero-labs-limited
Issuance Date
28 May 2024
Expiry Date
18 October 2029
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5066df1704766510
Type
Standard
Back to Philippines FDA Approvals
Paclitero - Philippines FDA Drug Approval Details